These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23462122)

  • 1. Genomic decoding of intrahepatic cholangiocarcinoma reveals therapeutic opportunities.
    Andersen JB; Thorgeirsson SS
    Gastroenterology; 2013 Apr; 144(4):687-90. PubMed ID: 23462122
    [No Abstract]   [Full Text] [Related]  

  • 2. Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes.
    Sia D; Hoshida Y; Villanueva A; Roayaie S; Ferrer J; Tabak B; Peix J; Sole M; Tovar V; Alsinet C; Cornella H; Klotzle B; Fan JB; Cotsoglou C; Thung SN; Fuster J; Waxman S; Garcia-Valdecasas JC; Bruix J; Schwartz ME; Beroukhim R; Mazzaferro V; Llovet JM
    Gastroenterology; 2013 Apr; 144(4):829-40. PubMed ID: 23295441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.
    Cao J; Sun L; Li J; Zhou C; Cheng L; Chen K; Yan B; Qian W; Ma Q; Duan W
    Oncol Rep; 2018 Sep; 40(3):1422-1434. PubMed ID: 29956786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low expression of ARID1A correlates with poor prognosis in intrahepatic cholangiocarcinoma.
    Yang SZ; Wang AQ; Du J; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG
    World J Gastroenterol; 2016 Jul; 22(25):5814-21. PubMed ID: 27433094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTPN3 mutations and HBV may exert synergistic effects in the origin of the intrahepatic cholangiocarcinoma.
    Cardinale V; Alvaro D
    Gastroenterology; 2014 Sep; 147(3):719-20. PubMed ID: 25075940
    [No Abstract]   [Full Text] [Related]  

  • 6. Liver resection for intrahepatic cholangiocellular carcinoma: when is it worthwhile?
    Pulitano C; Parks RW
    World J Surg; 2008 Dec; 32(12):2681-2. PubMed ID: 18850248
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic profiling of intrahepatic cholangiocarcinoma.
    Andersen JB; Thorgeirsson SS
    Curr Opin Gastroenterol; 2012 May; 28(3):266-72. PubMed ID: 22395571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overlapping signature genes between hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Chen F; Li S; Castranova V
    Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1320-1. PubMed ID: 19826380
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetics of hepatobiliary carcinogenesis.
    Nault JC; Zucman-Rossi J
    Semin Liver Dis; 2011 May; 31(2):173-87. PubMed ID: 21538283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global DNA methylation and hydroxymethylation differ in hepatocellular carcinoma and cholangiocarcinoma and relate to survival rate.
    Udali S; Guarini P; Moruzzi S; Ruzzenente A; Tammen SA; Guglielmi A; Conci S; Pattini P; Olivieri O; Corrocher R; Choi SW; Friso S
    Hepatology; 2015 Aug; 62(2):496-504. PubMed ID: 25833413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition.
    Seok JY; Na DC; Woo HG; Roncalli M; Kwon SM; Yoo JE; Ahn EY; Kim GI; Choi JS; Kim YB; Park YN
    Hepatology; 2012 Jun; 55(6):1776-86. PubMed ID: 22234953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYH Y165C and G382D mutations in hepatocellular carcinoma and cholangiocarcinoma patients.
    Baudhuin LM; Roberts LR; Enders FT; Swanson RL; Mettler TA; Aderca I; Stadheim LM; Highsmith WE
    J Cancer Res Clin Oncol; 2006 Mar; 132(3):159-62. PubMed ID: 16292541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of microRNA-203 in cholangiocarcinoma.
    Li J; Gao B; Huang Z; Duan T; Li D; Zhang S; Zhao Y; Liu L; Wang Q; Chen Z; Cheng K
    Int J Clin Exp Pathol; 2015; 8(8):9512-6. PubMed ID: 26464713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gallbladder and bile duct carcinoma. Biology and pathology].
    Tannapfel A; Wittekind C
    Internist (Berl); 2004 Jan; 45(1):33-41. PubMed ID: 14735242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of microsatellite instability, K-ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma.
    Isa T; Tomita S; Nakachi A; Miyazato H; Shimoji H; Kusano T; Muto Y; Furukawa M
    Hepatogastroenterology; 2002; 49(45):604-8. PubMed ID: 12063950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma.
    Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
    World J Surg; 2008 Dec; 32(12):2675-80. PubMed ID: 18843437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting the genetic susceptibility for cholangiocarcinoma in primary sclerosing cholangitis.
    Lazaridis KN
    Hepatology; 2008 Jan; 47(1):8-10. PubMed ID: 18161699
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined hepatocellular cholangiocarcinoma: Controversies to be addressed.
    Wang AQ; Zheng YC; Du J; Zhu CP; Huang HC; Wang SS; Wu LC; Wan XS; Zhang HH; Miao RY; Sang XT; Zhao HT
    World J Gastroenterol; 2016 May; 22(18):4459-65. PubMed ID: 27182157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 Mutations in human cholangiocarcinoma: a review.
    Khan SA; Thomas HC; Toledano MB; Cox IJ; Taylor-Robinson SD
    Liver Int; 2005 Aug; 25(4):704-16. PubMed ID: 15998419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges?
    Chiu CT; Chiang JM; Yeh TS; Tseng JH; Chen TC; Jan YY; Chen MF
    Dig Liver Dis; 2008 Sep; 40(9):749-54. PubMed ID: 18329969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.